PER 1.35% 7.5¢ percheron therapeutics limited

Sarepta FDA Hearing, page-80

  1. 520 Posts.
    lightbulb Created with Sketch. 331
    Oh ok thanks, I don't recall seeing that published. But that's actually my point. Even with positive data, I don't think Sarepta will be interested, IMO.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.